CIK 0001635077 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Aclarion, Inc.
Sign in to watch- Ticker
- ACON
- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 473324725
- Phone
- 833 275 2266
- Business address
- 8181 ARISTA PLACE, STE 100, BROOMFIELD, CO, 80021
- Former names
- Nocimed, Inc.
Securities
- ACON Common Stock Nasdaq
- ACONW Warrant Nasdaq
- NT 10-Q Other NT 10-Q
- 8-K/A Event Auditor change
- 8-K Event Delisting notice
- 4 Other disposition Executive Chairman disposed of 1 shares (other)
- 8-K Event Shareholder vote results · Other events
- 8-K Event Auditor change
- 8-K Event Delisting notice
- 10-K Report Annual Report
- DEF 14A Proxy Proxy Statement
- 4 Open-market buy Executive Chairman bought 1 shares at $1,000.00 ($1,000)
- 8-K Event Material agreement · Unregistered share sale · Bylaws or fiscal year change
- PRE 14A Proxy Proxy Statement (Preliminary)
- SC 13G Stake Amended Statement of Ownership
- 4 Open-market buy Chief Executive Officer bought 18,500 shares at an average $0.53 ($9,769)
- 4 Open-market buy Chief Financial Officer bought 22,404.44 shares at an average $0.45 ($10,000)
- 4 Derivatives Options or other derivatives
- 8-K Event Delisting notice
- 4/A Other acquisition Director acquired 152,128 shares (other)
- 4 Other disposition Former 10% Owner disposed of 1,091,894 shares (other)
- 4 Other disposition Director disposed of 152,128 shares (other)
Page 11 of 14 · 276 filings